December 1, 2013
Bookmark and Share  
 
                 
  HCV
»
»
»
»
»



Follow us on
Twitter

HCVAdvocate


Join us on Facebook
Hcvadvocate Hcsp

 

Greetings:

The AASLD conference this year was awesome!  There was so much information that it was mind boggling!  This issue of the HCV Advocate newsletter is all about AASLD.  In addition we have compiled all of our conference coverage (including the newsletter coverage) and put it into a Guide that provides one-stop shopping for everything AASLD.

In addition to the great news presented at AASLD, simeprevir (Olysio) was approved for the treatment of HCV genotype 1 – another important advancement in medications to treat HCV.

Best Regards,

Alan

 

1. A Guide to AASLD 2013: We are pleased to offer our first ‘Guide’ to AASLD 2013, containing a whole bunch of important information about hepatitis C and HIV/HCV coinfection.  Included in the guide is all of our coverage from AASLD including that from the December 2013 HCV Advocate newsletter.

AASLD Guide

Click Here

 

2. HCV Advocate Newsletter: December, 2013

In This Issue:

Check out our new fact sheets and the prescribing information for simeprevir (Olysio).

PDF Olysio (Simeprevir) –Easy C.

PDF Olysio (Simeprevir) –Fact Sheet.

PDF Olysio (Simeprevir) –Package Insert.

 

HEPATITIS B

3. HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B, including

  • Studies Find Hepatitis B Virus Can Mutate and Infect Even Immunized People
  • Hepatitis B Patients Appear to Be At Risk of Other Diseases
  • Experts: Do Not Rush to Treat HBV-Infected Children
  • Primary Care Doctors Essential in Treating Immigrants at Risk of Liver Cancer
  • Relapse Rate Low in Those Who Respond Well to Entecavir
  • Only 64% of U.S. Health Care Providers Are Immunized Against Hepatitis B
  • Studies Reveal Important Information about Hepatitis B in Women
  • Hepatitis B Risk in African Immigrants and African-Americans Studied

 

4 Easy B Fact SheetsWe have updated all of the Easy B fact sheets in the Diagnostic Tools & Markers, and Transmission / Prevention series.

 

5. HCV Advocate News & Pipeline Blog!
Be sure to check out the latest clinical trial postings at the HCV Advocate News & Pipeline Blog. Just click on the links to the Drug Companies below the banner to see which drugs are in trials right now, where the trials are, and how to register for one.

-----------------------------------

 

6.Need Help?!
Call 877-HELP-4-HEP line (877-435-7443). The helpline is open from 9:00am to 7:00pm Eastern Time.

———————————————


 

 and much, much more…..

 

Sincerely,

Alan

Alan Franciscus
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org

**Questions and Comments: Questions and/or comments can be directed to alanfranciscus@hcvadvocate.org

**To receive the eblast in your email inbox simply send an e-mail to: listserv@list.hcvadvocate.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.

 
  HBV
»
»
»

Follow us on Twitter
HBVAdvocate